CClinicalTrials.gg
CompletedNCT02403817Updated Dec 4, 2019Results posted

Training Attention and Eye Movement in ASD

An interventional study of Cognitive Training and Eye Motor Training in Autistic Disorder and Autism Spectrum Disorder, sponsored by University of California, San Diego. Completed at 1 site in United States. Open to participants aged 9 Years to 25 Years. Per ClinicalTrials.gov, last updated 2019-12-04.

Sponsored by University of California, San Diego · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
9 Years to 25 Years
Sex
All
01

Study summary

Current therapies for autism target social and language behaviors, but due to the high-level nature of these skills any improvement rarely extends beyond the targeted behavior. This project uses new technology to implement a novel concept for behavioral intervention to improve basic attention and eye movement skills in ASD. Because these basic skills form the foundation for good social communication, training these abilities has the potential to improve a broad spectrum of clinical symptoms, and in young children may affect the course of development.

Read the detailed description

Autism Spectrum Disorder (ASD) is a lifelong disorder that severely affects the ability to learn and function in a social environment. In typical function, higher level social, language and communication skills develop over the first few years of life and depend upon the critical building blocks of sensory-motor and attention abilities. Similarly in autism, higher level problems with social communication develop over the first two post-natal years and are preceded by subtle but abnormal visual attention and motor skills. Trainings to improve social interaction and communication are the most common of behavioral interventions in ASD. These therapies may improve the specific behaviors that are targets of the training, but rarely do they generalize to broader function or other clinical symptoms. The investigators propose that interventions aimed instead at the early deficits that support social and language skills would be more broadly effective. Because disruption of attention is one of the earliest and most persistent symptoms in autism, and because attention is highly subject to improvement with training, it is an important target for intervention.

This a novel intervention to train the speed and accuracy of attention orienting and eye movement. The training is designed to target attentional behaviors that have been shown to be impaired in autism, including attention orienting, disengagement and shifting, and a restricted attentional field. Because eye movement and attention are tightly linked, eye movement deficits in ASD parallel those found in spatial attention. Eye movements provide a marker for attention and the proposed training is designed to improve speed, accuracy and flexibility of eye movement and attention simultaneously. Training uses a series of entertaining video games to gradually shape behavior using visual and auditory feedback provided in real time. The investigators plan three levels of outcome measures for pre- and post-training to test the effectiveness of the intervention (direct tests of attention and eye movement; tests of improvement in attentional and visual monitoring and speed and accuracy of response in a simulated environment; tests of behavior in an actual social environment). The investigators will conduct clinical trials with control conditions (e.g., standard video games without training elements) with a small sample of ASD children aged 9-15. If this initial work is successful, the long term goal is to develop a readily available inexpensive eyetracker-based system for home use that is suitable for a broad age range of ASD children and adults.

02

Conditions studied

  • Autistic Disorder
  • Autism Spectrum Disorder

Keywords

  • Video Games
03

In context

Autism Spectrum Disorder

1,727 studies on the registry are indexed under Autism Spectrum Disorder; 504 are open to participants now.

This study's enrollment of 30 is below the median of 52 across 1,371 interventional studies indexed under Autism Spectrum Disorder.

Browse Autism Spectrum Disorder studies →

Lead sponsor

University of California, San Diego is the lead sponsor of 958 studies on the registry; 191 are open to participants now.

Of its 110 completed or terminated interventional studies of FDA-regulated products, 70 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participant has a diagnosis of Autism Spectrum Disorder (on Diagnostic and Statistical Manual -IV, Autism Diagnostic Observation Schedule, Autism Diagnostic Interview-Revised)
  • Participant has a nonverbal Intelligence Quotient (IQ) of 85 or greater and verbal IQ of 70 or greater
  • Cooperative and able to follow instructions
  • Normal hearing acuity
  • Normal or corrected-to-normal vision

Exclusion criteria

Exclusion Criteria:

  • Major medical or neurological problems including seizures, diagnosed epileptiform EEG abnormalities, migraine, tuberous sclerosis, fragile X, static encephalopathies resulting from prior Central Nervous System insults, significant premature birth, and history of exposure to teratogens, metabolic abnormalities, and history of head trauma, cerebral palsy, stroke, meningitis, brain tumor or additional psychiatric diagnoses
  • Participants currently participating in vision therapy will be excluded
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Eye Movement Game Control

    Cognitive Training Eye Motor Training

    Behavioral: Cognitive Training · Behavioral: Eye Motor Training

  • Active comparator
    Hand Movement Game Control

    Cognitive Training Hand Motor Training

    Behavioral: Cognitive Training · Behavioral: Hand Motor Training

Interventions

  • BehavioralCognitive Training

    A collection of video games that rely on various aspects of visual behavior (i.e. sustained attention, vigilance, rapid discrimination, etc) for successful play.

  • BehavioralEye Motor Training

    Game play will be controlled by the player's eye movements (via an eye tracking device)

  • BehavioralHand Motor Training

    Game play will be controlled by the player's hand movements (via a joystick).

06

What researchers measure

Primary outcomes

  1. Spatial Attention Baseline

    This behavioral task assesses the participant's baseline ability to rapidly and accurately shift visual attention to different spatial locations. This task also reveals whether a participant becomes overly-focused ('stuck') at specific locations.

    Time frame: Pre-intervention

  2. Saccadic Eye Movements Baseline

    This task uses an eyetracker to measure the baseline speed and accuracy of a participant's saccadic eye movements in response to various stimuli. Measure is accuracy of first saccade in the anti-saccade task.

    Time frame: Pre-intervention

  3. Change in Spatial Attention at 8 Weeks

    This behavioral task assesses the change in the participant's ability to rapidly and accurately shift visual attention to different spatial locations as a result of the intervention.

    Time frame: end of Week 8

  4. Change in Saccadic Eye Movements at 8 Weeks

    This task uses an eyetracker to measure the change in the speed and accuracy of a participant's saccadic eye movements in response to various stimuli as a result of the intervention. Measure is accuracy of first saccade in an anti-saccade task.

    Time frame: end of Week 8

07

Results

Posted Dec 4, 2019

Participant flow

Participant flow — Overall Study
MilestoneEye Movement Game ControlHand Movement Game Control
Started282
Completed232
Not completed50
Withdrew: Withdrawal by subject50

Outcome measures

PrimarySpatial Attention Baseline

This behavioral task assesses the participant's baseline ability to rapidly and accurately shift visual attention to different spatial locations. This task also reveals whether a participant becomes overly-focused ('stuck') at specific locations.

Time frame:
Pre-intervention
Reported as:
Mean · Percent Correct
Spatial Attention Baseline
Percent CorrectEye Movement Game ControlHand Movement Game Control
Spatial Attention Baseline80.3 ± 14.843.0 ± 26.9
PrimarySaccadic Eye Movements Baseline

This task uses an eyetracker to measure the baseline speed and accuracy of a participant's saccadic eye movements in response to various stimuli. Measure is accuracy of first saccade in the anti-saccade task.

Time frame:
Pre-intervention
Reported as:
Mean · percent correct direction
Saccadic Eye Movements Baseline
percent correct directionEye Movement Game ControlHand Movement Game Control
Saccadic Eye Movements Baseline49.20 ± 2.8—
PrimaryChange in Spatial Attention at 8 Weeks

This behavioral task assesses the change in the participant's ability to rapidly and accurately shift visual attention to different spatial locations as a result of the intervention.

Time frame:
end of Week 8
Reported as:
Mean · Percent Correct
Change in Spatial Attention at 8 Weeks
Percent CorrectEye Movement Game ControlHand Movement Game Control
Change in Spatial Attention at 8 Weeks88.07 ± 13.977.5 ± 16.3
Statistical analysis
  • Eye Movement Game Control · t-test, 2 sided · p = 0.00005
PrimaryChange in Saccadic Eye Movements at 8 Weeks

This task uses an eyetracker to measure the change in the speed and accuracy of a participant's saccadic eye movements in response to various stimuli as a result of the intervention. Measure is accuracy of first saccade in an anti-saccade task.

Time frame:
end of Week 8
Reported as:
Mean · Percent Correct Direction
Change in Saccadic Eye Movements at 8 Weeks
Percent Correct DirectionEye Movement Game ControlHand Movement Game Control
Change in Saccadic Eye Movements at 8 Weeks59.4 ± 2.7—
Statistical analysis
  • Eye Movement Game Control · t-test, 2 sided · p = 0.018

Adverse events

Collected over For each subject, data were collected from initial enrollment for 8 weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Eye Movement Game Control0/28 (0%)0/28 (0%)0/28 (0%)
Hand Movement Game Control0/2 (0%)0/2 (0%)0/2 (0%)

Baseline characteristics

These are the participants that completed the study.

Age, Continuous
Age, Continuous(years)Eye Movement Game ControlHand Movement Game ControlTotal
Mean17.31 ± 4.321.41 ± .417.62 ± 4.3
Sex: Female, Male
Sex: Female, Male(Participants)Eye Movement Game ControlHand Movement Game ControlTotal
Female505
Male18220
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Eye Movement Game ControlHand Movement Game ControlTotal
American Indian or Alaska Native000
Asian404
Native Hawaiian or Other Pacific Islander000
Black or African American000
White12214
More than one race707
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Eye Movement Game ControlHand Movement Game ControlTotal
United States23225
Autism Diagnosis
Autism Diagnosis(Participants)Eye Movement Game ControlHand Movement Game ControlTotal
Count of participants23225
08

Study locations

1 site
  • University of California San Diego
    La Jolla, California 92093-0959, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Aug 8, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — De-identified IPD is being shared through National Institutes of Health (NIH) National Database for Autism Research (NDAR).

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 4, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02403817
Lead sponsor
University of California, San Diego
Responsible party
Jeanne Townsend, PhD (Professor of Neurosciences, University of California, San Diego) — Principal investigator
First posted
Mar 31, 2015
Start date
Nov 2015
Primary completion
Aug 31, 2018
Completion
Aug 31, 2018
Results posted
Dec 4, 2019
Last update
Dec 4, 2019

Study contacts

Jeanne Townsend, Ph.D.
principal investigator · University of California, San Diego

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion